Vasculitis: Clinical Trials

15 trials for Vasculitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 unknown. 15 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 415Unknown 15

Follow Vasculitis: new trials by email Literature Review of Vasculitis trials Research Report on Vasculitis

Trials (filtered) newest first · largest first

All 15 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Stratified Therapy on Pediatric AAGN
GlucoCorticoid - Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, ANCA-Associated Glomerulonephritis
Phase 4UnknownWang Mo2002023-01-012023-08-01
Comparison of Adalimumab and Tofacitinib in the Treatment of Active Takayasu Arteritis
Adalimumab Injection, Tofacitinib 5 MG - Takayasu Arteritis
Phase 4UnknownChinese SLE Treatment And Research Group1002022-01-052023-07-24
Comparison of Tofacitinib and Methotrexate in the Maintained Treatment of GPA
Tofacitinib, Methotrexate - Granulomatosis With Polyangiitis
Phase 4UnknownShanghai Zhongshan Hospital662021-07-012021-07-09
Efficiency of Methotrexate and Tofacitinib in Mild and Moderate Patients
Methotrexate Tablets, Tofacitinib tablet - Takayasu Arteritis, Methotrexate
Phase 4UnknownShanghai Zhongshan Hospital1302020-03-012020-06-12
Efficacy and Safety of H.P. ACTHAR GEL in Adults With Retinal Vasculitis
H.P. ACTHAR GEL - Uveitis, Posterior, Vasculitis Retinal
Phase 4UnknownOcular Immunology and Uveitis Foundation402017-03-222019-09-12
Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome
Dapsone, HLA-B*1301 - Allergic Cutaneous Vasculitis, Urticaria
Phase 4UnknownShandong Provincial Institute of Dermatology and Venereology31302015-07-012017-03-03
Tocilizumab Dose-tapering and Interruption in Patients With Giant Cell Arteritis Achieving the Clinical Remission.
Tocilizumab - Giant Cell Arteritis
Phase 4UnknownHospital of Prato152015-01-012017-08-10
Low-dose Glucocorticoid Vasculitis Induction Study
Rituximab, Glucocorticoids - Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Microscopic Polyangiitis
Phase 4UnknownChiba University1402014-10-012021-01-27
Alemtuzumab for ANCA Associated Refractory Vasculitis
Alemtuzumab - Vasculitis, Microscopic Polyangiitis
Phase 4UnknownCambridge University Hospitals NHS Foundation Trust242011-02-012011-07-29
Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases
Anti-pandemic H1N1 influenza vaccine - Rheumatoid Arthritis, Spondyloarthritis
Phase 4UnknownUniversity of Sao Paulo50002010-04-012010-06-28
The Efficacy of Methylprednisolone in the Treatment of Patients With Ocular Involvement in Behcet's Disease
methylorednisolone, dextrose water 5% - Behcet's Disease
Phase 4UnknownTehran University of Medical Sciences342010-02-012011-03-02
Steroids Pharmacokinetics and the Response to Prednisone Therapy in Giant Cell Arteritis
Prednisone therapy and pharmacokinetic - Giant Cell Arteritis
Phase 4UnknownUniversity Hospital, Caen1502009-07-012014-04-09
Flucinolone Acetonide Implant for Treating Refractory Ocular Behcet's Disease
flucinolone acetonide - Ocular Behcet's Disease,, Non-Infectious Uveitis
Phase 4UnknownAsan Medical Center152008-07-012008-07-29
CHUSPAN PAN BP Treatment of Polyarteritis Nodosa and Microscopic Polyangiitis Without Poor-Prognosis Factors
azathioprine, cyclophosphamide - Polyarteritis Nodosa, Microscopic Polyangiitis
Phase 4UnknownHospices Civils de Lyon1241996-07-012006-11-16
CHUSPAN SCS BP Treatment of Churg-Strauss Syndrome Without Poor-Prognosis Factors
azathioprine, cyclophosphamide - Churg-Strauss Syndrome
Phase 4UnknownHospices Civils de Lyon721996-07-012006-11-14

Narrower conditions

Granulomatosis with Polyangiitis (3)  ·  Microscopic Polyangiitis (3)  ·  Uveitis, Posterior (3)  ·  Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (2)  ·  Behcet Syndrome (2)  ·  Giant Cell Arteritis (2)  ·  Retinal Vasculitis (2)  ·  Takayasu Arteritis (2)  ·  Acne Vulgaris (1)  ·  Antiphospholipid Syndrome (1)  ·  Aortitis (1)  ·  Arthritis, Juvenile (1)  ·  Arthritis, Rheumatoid (1)  ·  Churg-Strauss Syndrome (1)

Broader conditions

Cardiovascular Diseases (15)  ·  Vascular Diseases (15)  ·  Skin Diseases (14)  ·  Skin and Connective Tissue Diseases (14)  ·  Skin Diseases, Vascular (13)  ·  Immune System Diseases (10)  ·  Autoimmune Diseases (9)  ·  Nervous System Diseases (6)  ·  Systemic Vasculitis (6)  ·  Arteritis (5)  ·  Brain Diseases (5)  ·  Central Nervous System Diseases (5)  ·  Cerebrovascular Disorders (5)  ·  Respiratory Tract Diseases (5)

Interventions

Cyclophosphamide (3)  ·  tofacitinib (3)  ·  Azathioprine (2)  ·  Glucocorticoids (2)  ·  Methotrexate (2)  ·  Rituximab (2)  ·  Adalimumab (1)  ·  Alemtuzumab (1)  ·  Dapsone (1)  ·  Fluocinolone Acetonide (1)  ·  Prednisolone (1)  ·  tocilizumab (1)

Sponsors

Hospices Civils de Lyon (2)  ·  Shanghai Zhongshan Hospital (2)  ·  Asan Medical Center (1)  ·  Cambridge University Hospitals NHS Foundation Trust (1)  ·  Chiba University (1)  ·  Chinese SLE Treatment And Research Group (1)  ·  Hospital of Prato (1)  ·  Ocular Immunology and Uveitis Foundation (1)  ·  Shandong Provincial Institute of Dermatology and Venereology (1)  ·  Tehran University of Medical Sciences (1)  ·  University Hospital, Caen (1)  ·  University of Sao Paulo (1)  ·  Wang Mo (1)

Countries

China (5)  ·  Switzerland (2)  ·  Brazil (1)  ·  France (1)  ·  Iran (1)  ·  Italy (1)  ·  Japan (1)  ·  South Korea (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Lindi Jiang, PhD (2)  ·  David RW Jayne, MD MRCP (1)  ·  Farhad Shahram, Professor (1)  ·  Furen Zhang (1)  ·  Hiroshi Nakajima, M.D., Ph.D (1)  ·  Xiaofeng Zeng, MD (1)  ·  Young Hee Yoon, MD (1)

Results publications

PMID 25153486, PMID 14558057, PMID 18240234, PMID 21540203, PMID 21859696, PMID 22089462, PMID 22298793, PMID 22674883, PMID 22908326, PMID 22931582, PMID 22949223, PMID 22992045, PMID 23123020, PMID 23525305, PMID 23590801, PMID 23818263, PMID 24961747, PMID 25697557, PMID 28968874, PMID 29247107, PMID 33164993, PMID 34061144, PMID 35365179, PMID 37734880

NIH funding

2008 (1), 2009 (1)